Acute tubular necrosis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Acute tubular necrosis}}
{{Acute tubular necrosis}}
{{CMG}}; {{AE}} {{CK}}
{{CMG}}; {{AE}} [[User:Ayesha A. Khan|Ayesha A. Khan, MD]][mailto:Ayesha.khan@stvincentcharity.com] {{CK}}


==Overview==
==Overview==


Acute tubular necrosis (ATN) defines a pathologic process rather than a clinical syndrome in which varying degrees of renal tubular injury occur. Clinically, ATN manifests as acute kidney injury although the terms have previously been used interchangeably. ATN is the most common cause of overt AKI. Despite the term, ATN does not necessarily imply cellular necrosis with evidence of non-necrotic injury observed more consistently. Furthermore, clinicopathologic correlation is often irrelevant with severe renal insufficiency sometimes seen with modest pathological findings.<ref name="pmid18235086">{{cite journal| author=Rosen S, Stillman IE| title=Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. | journal=J Am Soc Nephrol | year= 2008 | volume= 19 | issue= 5 | pages= 871-5 | pmid=18235086 | doi=10.1681/ASN.2007080913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18235086  }} </ref>  ATN can be either ischemic or toxin induced. Classically, ischemic ATN follows hypotension or hypovolemia with patchy involvement usually observed. On the other hand, toxic ATN is usually a dose-dependent injury seen with medications, diagnostic agents, and heavy metals with proximal tubule damage involving almost all nephrons.<ref name="Fogo">Fogo A, Cohen AH, Colvin RB et al. Fundamentals of Renal Pathology. Springer 2013.  Acute Tubular Necrosis. http://dx.doi.org/10.1007/978-3-642-39080-7_15 </ref>
Acute tubular necrosis (ATN) defines a pathologic process rather than a clinical syndrome in which varying degrees of renal tubular injury occur. Clinically, ATN manifests as acute kidney injury although the terms have previously been used interchangeably. ATN is the most common cause of overt AKI. Despite the term, ATN does not necessarily imply cellular necrosis with evidence of non-necrotic injury observed more consistently. Furthermore, clinicopathologic correlation is often irrelevant with severe renal insufficiency sometimes seen with modest pathological findings.<ref name="pmid18235086">{{cite journal| author=Rosen S, Stillman IE| title=Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. | journal=J Am Soc Nephrol | year= 2008 | volume= 19 | issue= 5 | pages= 871-5 | pmid=18235086 | doi=10.1681/ASN.2007080913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18235086  }} </ref>  ATN can be either ischemic or toxin induced. Classically, ischemic ATN follows hypotension or hypovolemia with patchy involvement usually observed. On the other hand, toxic ATN is usually a dose-dependent injury seen with medications, diagnostic agents, and heavy metals with proximal tubule damage involving almost all nephrons.<ref name="Fogo">Fogo A, Cohen AH, Colvin RB et al. Fundamentals of Renal Pathology. Springer 2013.  Acute Tubular Necrosis. http://dx.doi.org/10.1007/978-3-642-39080-7_15 </ref>


==Historical Perspective==
==Historical Perspective==
Eric and beallduring was the first to publish a article on describing ATN in detail during world war II. In 1938, Councilman was the first to discover the association between systemic infections and the development of ATN.


==Classification==
==Classification==
Line 14: Line 14:


==Pathophysiology==
==Pathophysiology==
Classically the course of ischemic ATN has been divided into 3 phases: Initiation, maintenance, and recovery. During the initiation phase, immediately following the insult, sublethal cellular injury occurs, with loss of cell polarity and brush border. The maintenance phase is reached after the irreversible renal parenchymal injury has been established. During the last 2 phases, both tubular cell death and cell regeneration occur simultaneously. Apoptosis has been reported in the initial phase of acute tubular necrosis and during the recovery phase. With initial ischemic or cytotoxic injury, a number of tubular cells may undergo apoptosis. The ET-1 gene has also been shown to be upregulated during ischemic injuries. When exposed to ischemic stress, tubular cells are prone to loss polarity and even detachment of viable cells due to the disruption of key structural anchors. Several important proteins are required for tubular cells to maintain their structure and polarity including the actin cytoskeleton, microvilli, and junctional complexes such as tight junctions and adherens junctions. The most common cause of acute kidney injury (AKI) is acute tubular necrosis (ATN) when the pattern of injury lies within the kidney (intrinsic disease). The term tubular necrosis is a misnomer, as true cellular necrosis is usually minimal, and the alteration is not limited to the tubular structures. Acute tubular necrosis is most common in hospitalized patients and is associated with high morbidity and mortality. The pattern of injury that defines acute tubular necrosis includes renal tubular cell damage and death. Intrarenal vasoconstriction or a direct effect of drug toxicity is caused by an ischemic event, nephrotoxic mechanism, or a mixture of both.


==Causes==
==Causes==
Acute tubular necrosis is commonly caused by [[Kidney|renal]] [[ischemia]] resulting from conditions such as [[Hypovolemia|volume depletion]], [[hypotension]], [[Sepsis|septic shock]], [[cirrhosis]], and [[Disseminated intravascular coagulation|DIC]]. It is also caused by exposure to various nephrotoxic medications including [[Aminoglycoside|aminoglycosides]], [[amphotericin B]], [[ACE inhibitor|ACE inhibitors]], [[Non-steroidal anti-inflammatory drug|NSAIDs]], antiviral drugs, [[Chemotherapy|cytotoxic therapy]],and also exposure to [[Contrast media|radio contrast substances]].
Acute tubular necrosis is commonly caused by [[Kidney|renal]] [[ischemia]] resulting from conditions such as [[Hypovolemia|volume depletion]], [[hypotension]], [[Sepsis|septic shock]], [[cirrhosis]], and [[Disseminated intravascular coagulation|DIC]]. It is also caused by exposure to various nephrotoxic medications including [[Aminoglycoside|aminoglycosides]], [[amphotericin B]], [[ACE inhibitor|ACE inhibitors]], [[Non-steroidal anti-inflammatory drug|NSAIDs]], antiviral drugs, [[Chemotherapy|cytotoxic therapy]],and also exposure to [[Contrast media|radio contrast substances]].


==Differentiating Xyz from Other Diseases==
==Differentiating Acute tubular necrosis from Other Diseases==


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 68: Line 69:
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
According to the Kidney Disease Improving Global Outcomes (KDIGO) 2012 guidelines, management approach of acute tubular necrosis include examination of all patients thoroughly to identify the cause, precipitating factors, and comorbid conditions leading to a rapid reduction in GFR, which may be reversible and regular monitor patients for serum creatinine, BUN, and urine output to assess the severity of renal damage.


===Surgery===
===Surgery===
Line 73: Line 75:


===Primary Prevention===
===Primary Prevention===
Effective measures for the [[primary prevention]] of acute tubular necrosis include identification of individuals who are at high risk and prompt treatment for underlying conditions, maintain volume status and adequate [[Kidney|renal]] perfusion by proper [[hydration]], isotonic fluid administration, monitoring urine output and serum [[creatinine]] levels regular intervals to ensure normal renal function and avoiding or decreasing dose of nephrotoxins and [[Contrast medium|contrast media]].
Effective measures for the [[primary prevention]] of acute tubular necrosis include identification of individuals who are at high risk and prompt treatment for underlying conditions, maintain volume status and adequate [[Kidney|renal]] perfusion by proper [[hydration]] or isotonic fluid administration, monitoring fluid intake, urine output and serum [[creatinine]] levels regular intervals to ensure normal renal function and avoiding or decreasing dose of nephrotoxins and [[Contrast medium|contrast media]].


===Secondary Prevention===
===Secondary Prevention===

Latest revision as of 20:08, 17 May 2020

Acute tubular necrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute tubular necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute tubular necrosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute tubular necrosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute tubular necrosis overview

CDC on Acute tubular necrosis overview

Acute tubular necrosis overview in the news

Blogs on Acute tubular necrosis overview

Directions to Hospitals Treating Acute tubular necrosis

Risk calculators and risk factors for Acute tubular necrosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayesha A. Khan, MD[2] Chandrakala Yannam, MD [3]

Overview

Acute tubular necrosis (ATN) defines a pathologic process rather than a clinical syndrome in which varying degrees of renal tubular injury occur. Clinically, ATN manifests as acute kidney injury although the terms have previously been used interchangeably. ATN is the most common cause of overt AKI. Despite the term, ATN does not necessarily imply cellular necrosis with evidence of non-necrotic injury observed more consistently. Furthermore, clinicopathologic correlation is often irrelevant with severe renal insufficiency sometimes seen with modest pathological findings.[1] ATN can be either ischemic or toxin induced. Classically, ischemic ATN follows hypotension or hypovolemia with patchy involvement usually observed. On the other hand, toxic ATN is usually a dose-dependent injury seen with medications, diagnostic agents, and heavy metals with proximal tubule damage involving almost all nephrons.[2]

Historical Perspective

Eric and beallduring was the first to publish a article on describing ATN in detail during world war II. In 1938, Councilman was the first to discover the association between systemic infections and the development of ATN.

Classification

Acute tubular necrosis may be classified based on mechanisms of tubular injury into three categories ischemic, toxin-induced, and mixed.

Pathophysiology

Classically the course of ischemic ATN has been divided into 3 phases: Initiation, maintenance, and recovery. During the initiation phase, immediately following the insult, sublethal cellular injury occurs, with loss of cell polarity and brush border. The maintenance phase is reached after the irreversible renal parenchymal injury has been established. During the last 2 phases, both tubular cell death and cell regeneration occur simultaneously. Apoptosis has been reported in the initial phase of acute tubular necrosis and during the recovery phase. With initial ischemic or cytotoxic injury, a number of tubular cells may undergo apoptosis. The ET-1 gene has also been shown to be upregulated during ischemic injuries. When exposed to ischemic stress, tubular cells are prone to loss polarity and even detachment of viable cells due to the disruption of key structural anchors. Several important proteins are required for tubular cells to maintain their structure and polarity including the actin cytoskeleton, microvilli, and junctional complexes such as tight junctions and adherens junctions. The most common cause of acute kidney injury (AKI) is acute tubular necrosis (ATN) when the pattern of injury lies within the kidney (intrinsic disease). The term tubular necrosis is a misnomer, as true cellular necrosis is usually minimal, and the alteration is not limited to the tubular structures. Acute tubular necrosis is most common in hospitalized patients and is associated with high morbidity and mortality. The pattern of injury that defines acute tubular necrosis includes renal tubular cell damage and death. Intrarenal vasoconstriction or a direct effect of drug toxicity is caused by an ischemic event, nephrotoxic mechanism, or a mixture of both.

Causes

Acute tubular necrosis is commonly caused by renal ischemia resulting from conditions such as volume depletionhypotensionseptic shockcirrhosis, and DIC. It is also caused by exposure to various nephrotoxic medications including aminoglycosidesamphotericin BACE inhibitorsNSAIDs, antiviral drugs, cytotoxic therapy,and also exposure to radio contrast substances.

Differentiating Acute tubular necrosis from Other Diseases

Epidemiology and Demographics

Incidence of acute tubular necrosis is approximately 88 per 100,000 individuals worldwide. The mean age at diagnosis of acute tubular necrosis was 59.5 years. Mortality rate is high with acute tubular necrosis among hospitalized and ICU patients. Acute tubular necrosis affects men and women equally.

Risk Factors

Common risk factors in the development of acute tubular necrosis include any condition that lead to decreased renal perfusion such as recent abdominal and cardiac surgery, marked hypovolemiasepsishemorrhagic shock, severe pancreatitis, and diabetes mellitus. Nephrotoxic medications ( eg, ACE inhibitorsNSAIDsaminoglycosides, radio contrast media) can also be a risk for developing acute tubular necrosis.

Screening

Screening for acute tubular necrosis is usually not recommended for asymptomatic individuals. Screening is usually recommended for patients who are at high risk for developing acute tubular necrosis. Screening evaluation includes measurement of serum creatinine, urine output, blood urea nitrogen, urinary and serum electrolytes.

Natural History, Complications, and Prognosis

Acute tubular necrosis may usually develop through 3 phases, initiation, maintenance and recovery. Common complications of acute tubular necrosis include electrolyte imbalance(eg, hyperkalemiahyperphosphatemiahypocalcemia, and metabolic acidosis), platelet dysfunction and altered consciousness or comaPrognosis depends on the underlying etiology and severity of kidney damage. When compared to ischemic acute tubular necrosis, nephrotoxic and mixed acute tubular necrosis have the good prognosis.

Diagnosis

Diagnostic Study of Choice

There is no single diagnostic study of choice for the diagnosis of acute tubular necrosis, but acute tubular necrosis can be diagnosed based on serum creatinine and BUN levels, urinalysis, urine electrolytes (urine sodiumfractional excretion of sodium concentration), and ultrasonography with doppler imaging.

History and Symptoms

History taking is an important aspect in making a diagnosis of acute tubular necrosis. It provides clues to precipitating factors, causes and associated comorbid conditions leading to decreased renal perfusion and kidney injury. Most common symptoms of acute tubular necrosis include decreased or absent urinary output, postural dizzinessedema, excess thirsttachycardiaaltered mental status and easy fatiguability.

Physical Examination

On physical examinationpatients with acute tubular necrosis may show the findings of volume depletion. They usually appear illdehydrated, and lethargic. Common physical examinationfindings of acute tubular necrosis include orthostatic hypotension and other signs of hypovolemia (dry mucous membranes, sunken eyes, poor skin turgor and delayed capillary refill, and decreased jugular venous pressure).

Laboratory Findings

CBCurinalysis with sediment microscopyurine electrolytes, osmolarity, serum electrolytes, blood urea nitrogen and serum creatinine, and urine dipstick are commonly performed in patients to evaluate acute tubular necrosis and other causes of acute renal failureUrine sediment may show tubular epithelial cells and epithelial cell casts or brown muddy granular casts. Increased urine sodium concentration >40 mEq/L, urine fractional excretion of sodium greater than 2 percent along with elevated serum creatinine concentration at a rate greater than 0.3 mg/dL/day may be found in acute tubular necrosis. However, these tests may have some limitations.

Electrocardiogram

There are no ECG findings associated with acute tubular necrosis. An ECG may be helpful in the diagnosis of electrolyte imbalance occurs as a complication of acute tubular necrosis.

X-ray

There are no specific x-ray findings associated with acute tubular necrosis. However, an abdominal x-ray may be helpful in diagnosing renal calculi, and areas of obstruction.

Echocardiography and Ultrasound

Ultrasound with doppler imaging can be helpful in the diagnosis of acute tubular necrosis. Findings on an ultrasound include normal or increased kidney size, alterations in cortical echogenicityand increased RI. There are no echocardiography findings associated with acute tubular necrosis. However, an echocardiography may be helpful in the diagnosis of complications of acute tubular necrosis.

CT scan

CT scan findings of patients with acute tubular necrosis may include alterations in kidney size, striate nephrogram, accumulation of fluid around kidneys. CT scan can also detect hydronephrosis that cannot be detectable on ultrasound.

MRI

There are no specific MRI findings associated with acute tubular necrosis. MRI may show alteration in kidney size, outflow obstruction areas that can not be clearly visible on ultrasound.

Other Imaging Findings

There are no other imaging findings associated with acute tubular necrosis.

Other Diagnostic Studies

Renal biopsy and detection of various novel biomarkers in the serum and urine can be helpful in diagnosing acute tubular necrosis.

Treatment

Medical Therapy

According to the Kidney Disease Improving Global Outcomes (KDIGO) 2012 guidelines, management approach of acute tubular necrosis include examination of all patients thoroughly to identify the cause, precipitating factors, and comorbid conditions leading to a rapid reduction in GFR, which may be reversible and regular monitor patients for serum creatinine, BUN, and urine output to assess the severity of renal damage.

Surgery

Surgery is not the first-line treatment option for patients with acute tubular necrosis.

Primary Prevention

Effective measures for the primary prevention of acute tubular necrosis include identification of individuals who are at high risk and prompt treatment for underlying conditions, maintain volume status and adequate renal perfusion by proper hydration or isotonic fluid administration, monitoring fluid intake, urine output and serum creatinine levels regular intervals to ensure normal renal function and avoiding or decreasing dose of nephrotoxins and contrast media.

Secondary Prevention

Secondary preventive measures of acute tubular necrosis are similar to primary prevention.

References

  1. Rosen S, Stillman IE (2008). "Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation". J Am Soc Nephrol. 19 (5): 871–5. doi:10.1681/ASN.2007080913. PMID 18235086.
  2. Fogo A, Cohen AH, Colvin RB et al. Fundamentals of Renal Pathology. Springer 2013. Acute Tubular Necrosis. http://dx.doi.org/10.1007/978-3-642-39080-7_15